Search Results - "Sowder RC 2nd"

Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel.

Authors: Teleshova, Natalia Keller, Marla J. Fernández Romero, José A. et al.

Source: PLoS ONE. 1/20/2022, Vol. 17 Issue 1, p1-24. 24p.

The host cytoskeleton: a key regulator of early HIV‐1 infection.

Authors: Stephens, Christopher Naghavi, Mojgan H.

Source: FEBS Journal. May2024, Vol. 291 Issue 9, p1835-1848. 14p.

Fighting nature with nature: antiviral compounds that target retroviruses.

Authors: Siew, Zhen Yun Asudas, Elishea Khoo, Chia Ting et al.

Source: Archives of Microbiology. Mar2024, Vol. 206 Issue 3, p1-16. 16p.

New lectins from Codium isthmocladum Vickers show unique amino acid sequence and antibiofilm effect on pathogenic bacteria.

Authors: Carneiro, Rômulo Farias Duarte, Philippe Lima Chaves, Renata Pinheiro et al.

Source: Journal of Applied Phycology. 2020, Vol. 32 Issue 6, p4263-4276. 14p.

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo.

Authors: Crakes, Katti R Herrera, Carolina Morgan, Jessica L et al.

Source: Journal of the International AIDS Society. Oct2020, Vol. 23 Issue 10, p1-12. 12p. 1 Chart, 3 Graphs, 1 Map.

The green microalgae Tetradesmus obliquus (Scenedesmus acutus) as lectin source in the recognition of ABO blood type: purification and characterization.

Authors: Silva, A. J. Cavalcanti, V. L. R. Porto, A. L. F. et al.

Source: Journal of Applied Phycology. Feb2020, Vol. 32 Issue 1, p103-110. 8p.

Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232.

Authors: Smith, Robert A. Raugi, Dana N. Nixon, Robert S. et al.

Source: PLoS ONE. 1/18/2023, Vol. 18 Issue 1, p1-21. 21p.

Exploring value-added compounds from tropical marine plants.

Authors: Yi Xin Mingting Du Xinjun Yu et al.

Source: Tropical Plants. 2023, Vol. 2 Issue 1, p1-9. 9p.

The Updated Review on Plant Peptides and Their Applications in Human Health.

Authors: Mani, Saiprahalad Bhatt, Smruti B. Vasudevan, Vinduja et al.

Source: International Journal of Peptide Research & Therapeutics. Sep2022, Vol. 28 Issue 5, p1-47. 47p.

Lectins Are the Sparkle of Hope for Combating Coronaviruses and the Global COVID-19.

Authors: Abbas, Heba Salah Kotakonda, Muddukrishnaiah

Source: Advanced Pharmaceutical Bulletin. 2022, Vol. 12 Issue 2, p319-328. 10p.

A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.

Authors: Cai, Yanxing Xu, Wei Tang, Jiayi et al.

Source: Cell & Bioscience. 7/8/2021, Vol. 11 Issue 1, p1-14. 14p.

Antiviral Activity of Innate Immune Protein ISG15.

Authors: Harty, Ronald N. Pitha, Paula M. Okumura, Atsushi

Source: Journal of Innate Immunity. 2009, Vol. 1 Issue 5, p397-404. 8p.

An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors: Lotfi, Hajie Sheervalilou, Roghayeh Zarghami, Nosratollah

Source: BioImpacts. Apr2018, Vol. 8 Issue 2, p139-151. 13p.

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins.

Authors: Jan, Muzafar Upadhyay, Chitra Alcami Pertejo, José et al.

Source: PLoS ONE. 3/26/2018, Vol. 13 Issue 3, p1-21. 21p.

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.

Authors: Fennessey, Christine M. Pinkevych, Mykola Immonen, Taina T. et al.

Source: PLoS Pathogens. 5/4/2017, Vol. 13 Issue 5, p1-28. 28p.

Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.

Authors: Hahn, Friedrich Schmalen, Adrian Setz, Christian et al.

Source: PLoS ONE. 4/7/2017, Vol. 12 Issue 4, p1-29. 29p.

Survivors Remorse: antibody-mediated protection against HIV-1.

Authors: Lewis, George K. Pazgier, Marzena DeVico, Anthony L.

Source: Immunological Reviews. Jan2017, Vol. 275 Issue 1, p271-284. 14p.

The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.

Authors: Pachulska-Wieczorek, Katarzyna Błaszczyk, Leszek Biesiada, Marcin et al.

Source: Retrovirology. 3/17/2016, Vol. 13, p2-15. 14p.

Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.

Authors: Ng, Tzi Cheung, Randy Wong, Jack et al.

Source: Applied Microbiology & Biotechnology. Dec2015, Vol. 99 Issue 24, p10399-10414. 16p.

ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag.

Authors: Minako Ogawa Yuki Takemoto Shintaro Sumi et al.

Source: Retrovirology. 11/17/2015, Vol. 12, p1-13. 13p.